Knowledge Graph:

From Data Silos to Connected Insights

Transform Fragmented Experimental Data into Assets

Over 97% of an organisation’s evidence is buried in silos and impossible to access. Quark Knowledge Graph connects fragmented data: → surfacing insights, revealing non-obvious connections, & transforming proprietary data into competitive assets.

Zero Hallucinations. Zero Vendor Lock-In.

Your Proprietary Data Is Your Competitive Asset.

Around 85–95% of preclinical evidence never reaches a bench-scientist's desk and stays buried in silos. Quark connects it. Unify your internal multimodal data — RWD, clinical, multi-omics, negative results — with public repositories into a single accessible knowledge graph.

Your Infrastructure. Your Code. Your Data. No Lock-In.

Quark deploys entirely within your own AWS account. The full codebase is delivered to you at deployment, along with the schema which you can extend. No vendor cloud. No proprietary schema lock-in. No data movement agreements.

Structure Once. Query Forever.

Quark transorms your multimodal data into a unified, AI-accessible graph following the OMOP CDM standardisation framework. Every experiment you add enriches every future query — turning your knowledge graph into an appreciating asset.

Generate Reproducible Research Intelligence by Design.

Quark answers queries through deterministic graph traversal — not LLM generation. Results are traceable, auditable, & hallucination-free. Purpose-built for high-scrutiny target identification, biomarker discovery, and drug development workflows.

Reveal Hidden Patterns with Natural Language Based Interactions.

Query complex cross-dataset associations in natural language — no code, no bioinformatics queue. Reveal non-obvious associations through precise graph traversal across proprietary data and public repositories, in minutes.

Democratise Research Insights for Seamless Collaboration.

Instantly bring the latest research insights to bench-scientists, bioinformaticians, clinicians and physicians across the board through natural-language based interactions.

No More sorting through thousands of disease-target & drug-target associations. Our AI powered knowledge graph does it for you.
Interact using natural language. Experience 20X acceleration in target identification.

Transform Data With Simple Interactions

AI-Powered, Reproducible & Collaborative Research

Build Your Knowledgebase

Integrate your proprietary data with public repos (DGIdb, GO terms, cBioPortal, & clinicaltrials.gov)

Build Your Knowledgebase

Integrate your proprietary data with public repos (DGIdb, GO terms, cBioPortal, & clinicaltrials.gov)

Evolve Your Knowledgebase

Experience Day 0 transformation of complex data into an AI-accessible knowledgebase.

Evolve Your Knowledgebase

Experience Day 0 transformation of complex data into an AI-accessible knowledgebase.

Generate Research Intelligence

Immediately access AI & prioritise biomarkers from significant disease–target & drug–target associations.

Reveal Hidden Data Patterns

Find non-obvious associations between multimodal data with natural language based interactions.

Generate Research Intelligence

Immediately access AI & prioritise biomarkers from significant disease–target & drug–target associations.

Reveal Hidden Data Patterns

Find non-obvious associations between multimodal data with natural language based interactions.

Seamlessly Collaborate

Leverage your knowledge graph to instantly share the latest research insights with stakeholders across the board.

Seamlessly Collaborate

Leverage your knowledge graph to instantly share the latest research insights with stakeholders across the board.

Read about how Quark knowledge graph accelerates target identification here

Empower Precision Medicine

Unify public and proprietary data into a single queryable graph.

Learn, Connect, and Innovate

Recent Articles

Decoding Epigenomic Patterns with Quark

Epigenetics focuses on gene expression patterns independent of DNA sequences, notably through cytosine methylation. Understanding the methylome enhances insights into cellular functions, cancers, and aging. Quark simplifies methyl-seq data analysis, ensuring robust and reproducible results, essential for precision medicine and integrative analysis, while addressing complexity in interpretation and visualization.

Understanding Conserved Patterns by Leveraging scRNA-seq Integration

Single-cell RNA sequencing (scRNA-seq) enhances understanding of cellular heterogeneity, pivotal for cancer research. However, challenges like batch effects and data complexity hinder analysis. Quark provides an end-to-end solution through horizontal integration, facilitating robust comparative analyses, accelerating insights, and enhancing workflow accessibility, crucial for effective biomarker discovery and precision medicine.

Accelerating Proteomics Research for Biomarker Discovery in Clinical Applications

Proteomics is the comprehensive study of proteins in an organism that uncovers their dynamic roles and complexities. It aids biomarker discovery for diseases, improving drug development and treatment monitoring. Despite analytical challenges, advancements in mass spectrometry and platforms like Quark simplify data analysis, enabling researchers to identify and interpret crucial protein-related insights effectively.